IB told me I am owed a settlement for owning $709.HK in 2022. Sounds like a nightmare to cash (certification of ownership, getting a HK cheque no bank here will cash). Still a somewhat sizable amount; I think this was a big name on FinTwit back then; anybody actually doing this?
@hillfronter83 You'd imagine they would have know nbeforehand though. Also not sure why it took them over a month to close this deal after shareholder approval. We'll never know I guess (which probably explains the incentive to spend it all).
$MURA has apparently managed to spend quite a bit before being acquired by $XOMA. The "Additional Price Per Share" is zero. Nice farewell gift to its shareholders. Deal closes early December at the $2.035 minimum.
$ZYNE.CVR pays $0.27 on completion of Ph.3 trial by Harmony. The trial failed. Nice reminder how valuable 'completion' milestones (or 'NDA filing' or 'first dosing') sometimes are vs approval milestones (let alone sales related). Remaining CVR derisked but also likely worthless.
“We plan to file for approval before the end of this year, and we hope the regulators will agree with us,” Kosiborod said.
The filing will trigger a contingent value right of $10 per share in cash" https://t.co/XW3tVbZXdT
$CINC CVR looks in good shape after $AZN said baxdrostat Phase 3 trial was succesful. The CVR will pay $10 if/when an NDA is submitted. https://t.co/HTTIKOAUnU
@AnotherBio I think this makes sense. The $IGMS CVR just paid $0.11 in excess cash. Shares traded at implied value of $0.02 before close, Tang said in the merger proxy he expected $0.00-$0.02.
(if I ever blow up my account it's probably because of one of these deals. Stupidly chasing a very-unlikely-to-ever-pay CVR that costs very little but exposes you to huge risks -which you can't hedge because no options- if the deal somehow not closes for some black swan reason)
$VIGL takeover by $SNY has closed. Had me a little bit worried for a second when $VIGL suddenly filed a 10-Q describing the merger in future tense and emphasizing the various risks involved, but fortunately the 8-K announcing the closing followed 30 mins later.
Does anybody know what's going on with $HOOK? Liquidation play, will pay $1.28-$1.72, but no distribution for three years(!). Always seemed very overvalued when I looked, but now at $0.90 starting to get interesting. Potential shareholder vote problems maybe? Meeting on the 29th.
@hillfronter83 Where do you read the "three years after"? It seems to me they can file the certificate once the sale to Gilead closes and then go into winding-up mode for three years (or longer). I just don't get why they are unable to pay an initial distribution in the interim period.
@ljp0101 @107_taste @AnotherBio And/or little people like me that want exposure on the CVR but don't want to lose a night's sleep worrying about their account getting wiped out if they wake up to some sort of a black swan event (i.e. tender cancelled). That's esp relevant if cvr-part is small relative to cash.
$BPMC tender by $SNY has been extended but will be done tomorrow. Only 46% tendered, but another 36% (!) came in late by guaranteed delivery. Weird, never seen that. https://t.co/CkRdT4EcpA